These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11678430)

  • 1. Sex differences in length of survival with malignant astrocytoma, but not with glioblastoma.
    Diete S; Treuheit T; Dietzmann K; Schmidt U; Wallesch CW
    J Neurooncol; 2001 May; 53(1):47-9. PubMed ID: 11678430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade astrocytomas.
    Wen PY; Fine HA; Black PM; Shrieve DC; Alexander E; Loeffler JS
    Neurol Clin; 1995 Nov; 13(4):875-900. PubMed ID: 8584002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant astrocytic gliomas in children.
    Marchese MJ; Chang CH
    Cancer; 1990 Jun; 65(12):2771-8. PubMed ID: 2160318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low grade astrocytomas: controversies in management.
    Kaye AH; Walker DG
    J Clin Neurosci; 2000 Nov; 7(6):475-83. PubMed ID: 11029226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High grade astrocytomas in children: Hartford Hospital experience.
    Hall AJ; Wagle VG; Voytek T
    Conn Med; 1991 Mar; 55(3):135-8. PubMed ID: 1647288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary brain tumors].
    Cohen J; Cohen Y; Kuten A
    Harefuah; 1996 Nov; 131(10):387-90, 456. PubMed ID: 8981815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
    Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade glioma in children and adolescents: a single-center experience.
    Yazici G; Zorlu F; Cengiz M; Ozyigit G; Eren G; Yüce D; Varan A; Akyuz C; Akalan N; Gurkaynak M
    Childs Nerv Syst; 2016 Feb; 32(2):291-7. PubMed ID: 26679932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and prognostic factors of anaplastic gliomas.
    Nuño M; Birch K; Mukherjee D; Sarmiento JM; Black KL; Patil CG
    Neurosurgery; 2013 Sep; 73(3):458-65; quiz 465. PubMed ID: 23719055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Difference in the therapeutic efficacy between anaplastic astrocytoma and glioblastoma multiforme types].
    Kiya K; Uozumi T; Kurisu K; Mikami T; Hotta T; Ogasawara H; Sugiyama K; Fujita H
    Gan No Rinsho; 1990 Jun; 36(7):777-81. PubMed ID: 2162401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival analysis for high-grade glioma patients who received comprehensive treatment].
    Liu G; Jiang R; Xu C; Zhou J; Liu F; He Z; Liu Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):388-393. PubMed ID: 29774874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy.
    Shin JY; Diaz AZ
    J Neurooncol; 2016 Sep; 129(3):557-565. PubMed ID: 27401155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for recurrent malignant glioma: an interim report on survival.
    Ingram M; Buckwalter JG; Jacques DB; Freshwater DB; Abts RM; Techy GB; Miyagi K; Shelden CH; Rand RW; English LW
    Neurol Res; 1990 Dec; 12(4):265-73. PubMed ID: 1982172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retreatment of intracranial gliomas.
    Landy HJ; Feun L; Schwade JG; Snodgrass S; Lu Y; Gutman F
    South Med J; 1994 Feb; 87(2):211-4. PubMed ID: 8115886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of irradiation in patients with high-grade gliomas evaluated by magnetic resonance imaging.
    Seither RB; Jose B; Paris KJ; Lindberg RD; Spanos WJ
    Am J Clin Oncol; 1995 Aug; 18(4):297-9. PubMed ID: 7625369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant astrocytoma in South Australia: treatment and case survival.
    North B; Reilly P; Blumbergs P; Roder D; Esterman A
    Med J Aust; 1990 Sep; 153(5):250-4. PubMed ID: 2168013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors in malignant gliomas].
    Ushio Y; Kochi M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):643-8. PubMed ID: 8678527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications.
    Burger PC; Vogel FS; Green SB; Strike TA
    Cancer; 1985 Sep; 56(5):1106-11. PubMed ID: 2990664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.